Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOTICGeneric

BOROFAIR

ACETIC ACID, GLACIAL; ALUMINUM ACETATE

Standard Dose
2%;0.79%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BOROFAIR is listed in Drugs@FDA under application 088606 (ANDA).

Marketing status: Discontinued Active ingredient ACETIC ACID, GLACIAL; ALUMINUM ACETATE Form and strength SOLUTION/DROPS;OTIC - 2%;0.79% Sponsor PHARMAFAIR Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview BOROFAIR is listed in Drugs@FDA under application 088606 (ANDA). Marketing status: Discontinued Active ingredient ACETIC ACID, GLACIAL; ALUMINUM ACETATE Form and strength SOLUTION/DROPS;OTIC - 2%;0.79% Sponsor PHARMAFAIR Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.